Jong Wook Chang
Samsung Medical Center, South Korea
Title: The Application of Human Mesenchymal Stem Cell for Alzheimer’s Disease
Biography
Biography: Jong Wook Chang
Abstract
Various groups have presented findings that human mesenchymal stem cells (MSCs) have both immunomodulatory and trophic properties. MSCs tend to act indirectly at sites of injury or damage through the secretion of paracrine factors in vitro and in vivo. For example, our studies have been done using a transgenic Alzheimer’s disease mouse model where intraparenchymal injections of MSCs resulted in the reduction of amyloid plaque levels, anti-apoptosis, and activation of endogenous neural stem cell and also activate proteasome in neuron. In addition, efficient MSC delivery is also a significant issue for human study. By possessing a broad range of functions, MSCs hold great potential in being used as a novel treatment for various diseases including neurodegenerative disorders.